Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 0.8660
-0.0170 (-1.93%)
Sep 11, 2026, 5:36 PM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €12.6 million as of September 11, 2026. Its market cap has decreased by -30.85% in one year.
Market Cap
12.60M
Enterprise Value
30.25M
Revenue
6.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
ChartMarket Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 12.60M, a decrease of -88.76%. That is a compound annual growth rate of -22.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 12.60M | -48.60% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nicox | 31.37M |
| GenSight Biologics | 26.12M |
| genOway Société anonyme | 23.05M |
| Aelis Farma | 13.79M |
| Aton | 11.76M |
| NFL Biosciences | 10.90M |
| TME Pharma | 10.11M |
| Poxel | 9.94M |